Profile data is unavailable for this security.
About the company
Curative Biotechnology, Inc. is a development stage biomedical company focused on therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. It has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology. It is focused on its degenerative eye disease platform. The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage age-related macular degeneration (AMD) disease. Its pipeline products include IMT504, CURB906, Metformin Reformulation, and COVID Vaccine with IMT504 Adjuvant. IMT504 is an immunotherapy for late-stage symptomatic rabies. CURB906 is a humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor cancer site to kill the tumor by inhibiting tumor growth and migration of the tumor.
- Revenue in USD (TTM)0.00
- Net income in USD-6.02m
- Incorporated2007
- Employees4.00
- LocationCurative Biotechnology Inc1825 Nw Corporate Blvd., Suite 110BOCA RATON 33431United StatesUSA
- Phone+1 (561) 907-8990
- Websitehttps://curativebiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspira Women's Health Inc | 8.92m | -15.95m | 13.43m | 64.00 | -- | -- | -- | 1.50 | -1.45 | -1.45 | 0.801 | -0.2892 | 1.53 | 15.11 | 5.79 | 139,421.90 | -273.16 | -110.58 | -3,758.30 | -151.88 | 57.84 | 45.23 | -178.80 | -334.08 | 0.5542 | -17,354.00 | -- | -- | 11.85 | 24.56 | 44.15 | -- | -26.65 | -- |
Edesa Biotech Inc | 0.00 | -6.93m | 14.13m | 16.00 | -- | 4.93 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
Alterola Biotech Inc | 0.00 | -2.06m | 14.30m | 1.00 | -- | -- | -- | -- | -0.0017 | -0.0017 | 0.00 | -0.001 | 0.00 | -- | -- | 0.00 | -32.46 | -- | -46.53 | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | -- | -- | -14.64 | -- | -- | -- |
Senti Biosciences Inc | 338.00k | -78.62m | 14.34m | 48.00 | -- | 0.3244 | -- | 42.44 | -17.52 | -12.65 | 0.0749 | 9.66 | 0.0029 | -- | 1.12 | 7,041.67 | -68.20 | -- | -74.50 | -- | -- | -- | -23,259.47 | -- | -- | -- | 0.0023 | -- | -40.25 | -- | -67.94 | -- | -- | -- |
Curative Biotechnology Inc | 0.00 | -6.02m | 14.41m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
Apollomics Inc | 0.00 | -57.11m | 14.46m | 45.00 | -- | 0.695 | -- | -- | -0.568 | -0.568 | 0.00 | 0.1892 | 0.00 | -- | -- | 0.00 | -107.81 | -- | -144.29 | -- | -- | -- | -- | -- | -- | -- | 0.185 | -- | -- | -- | 28.33 | -- | -- | -- |
Microbot Medical Inc | 0.00 | -10.44m | 14.57m | 22.00 | -- | 2.33 | -- | -- | -0.81 | -0.81 | 0.00 | 0.3793 | 0.00 | -- | -- | 0.00 | -113.94 | -53.28 | -133.34 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
Protext Mobility Inc | 750.00 | -2.21m | 14.95m | 4.00 | -- | -- | -- | 19,926.77 | -0.4692 | -0.4692 | 0.00001 | -0.0102 | 0.0405 | -- | -- | -- | -9,400.97 | -1,587.94 | -- | -- | 86.67 | -530.19 | -232,392.00 | -17,498.83 | 0.0002 | -1.36 | -- | -- | -93.98 | -63.09 | 27.35 | -- | -- | -- |
IN8BIO, Inc. | 0.00 | -31.96m | 15.02m | 31.00 | -- | 1.09 | -- | -- | -0.8357 | -0.8357 | 0.00 | 0.2933 | 0.00 | -- | -- | 0.00 | -122.41 | -74.18 | -146.35 | -84.42 | -- | -- | -- | -- | -- | -- | 0.0945 | -- | -- | -- | -5.21 | -- | -4.54 | -- |
NKGen Biotech Inc | 0.00 | -88.25m | 15.12m | 63.00 | -- | -- | -- | -- | -3.74 | -3.74 | 0.00 | -2.71 | 0.00 | -- | -- | 0.00 | -480.25 | -- | -- | -- | -- | -- | -- | -- | -- | -0.4822 | -- | -- | -100.00 | -- | -210.06 | -- | -- | -- |
Indaptus Therapeutics Inc | 0.00 | -15.75m | 15.30m | 7.00 | -- | 2.08 | -- | -- | -1.86 | -1.86 | 0.00 | 0.7209 | 0.00 | -- | -- | 0.00 | -108.73 | -66.55 | -126.30 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
Imunon Inc | 0.00 | -18.08m | 15.41m | 33.00 | -- | 2.69 | -- | -- | -1.92 | -1.92 | 0.00 | 0.398 | 0.00 | -- | -- | 0.00 | -94.15 | -50.18 | -132.90 | -60.27 | -- | -- | -- | -5,725.88 | -- | -- | 0.00 | -- | -100.00 | -- | 45.64 | -- | 26.69 | -- |
Turnstone Biologics Corp | 0.00 | -74.70m | 15.60m | 82.00 | -- | 0.2612 | -- | -- | -3.49 | -3.49 | 0.00 | 2.58 | 0.00 | -- | -- | 0.00 | -98.52 | -- | -127.31 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -73.66 | -- | -78.05 | -- | -- | -- |